GlassScriptPhysician profile
Joseph Ramon Rozas
NPI 1174554737
$2,851.80
in general payments reported to CMS, 2019-2025
37 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $102 · 2021: $445 · 2022: $339 · 2023: $783 · 2024: $754 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $333.48 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $240.31 | 2019-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $221.11 | 2021-2024 | Dificid, Delstrigo, Pifeltro |
| Pfizer INC. | $201.29 | 2022-2025 | |
| Abbott Laboratories | $184.64 | 2020-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.06 | 2019-2024 | Jardiance |
| Astellas Pharma US INC | $162.60 | 2021-2025 | Myrbetriq, Veozah |
| Eisai INC. | $128.80 | 2021-2025 | |
| Exact Sciences Corporation | $125.39 | 2023-2025 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $123.74 | 2019 | |
| Lilly USA, LLC | $108.95 | 2021-2024 | Jardiance, Mounjaro |
| Inspire Medical Systems, INC. | $82.14 | 2024-2025 | Inspire |
| Corcept Therapeutics | $81.64 | 2023-2024 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.95 | 2023-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $66.25 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rozas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.